Literature DB >> 2853279

T cell hybridomas define the class II MHC-restricted response to vesicular stomatitis virus infection.

M A Petrarca1, C S Reiss, D C Diamond, J Boni, S J Burakoff, D V Faller.   

Abstract

T cell hybridomas with specificity for VSV (vesicular stomatitis virus)-infected cells were generated in an attempt to better define the la-restricted helper T cell response to VSV. The hybridomas were created by fusing BALB/c (H-2d) anti-VSV immune spleen cells to the murine thymoma BW 5147. These hybridomas produce IL-2 when stimulated with VSV-infected spleen cells. They were found to recognize viral antigens in association with I-Ad and, in addition, could also be stimulated by VSV-infected A20 cells (an Ia-positive B cell lymphoma of H-2d origin). The purified viral membrane glycoprotein, G protein, and Gs (secreted G protein that lacks the hydrophobic and intracytoplasmic domains) both stimulated IL-2 production when added to cultures of A20 and the hybridomas. These hybridomas therefore recognize a viral antigenic determinant on G protein. Since chemically-fixed antigen-presenting cells fail to stimulate the hybridomas after exogenous addition of purified G protein we can conclude that these T cell hybridomas recognize a processed form of the G protein. Stimulator cells created by expression in A20 of a transfected cDNA encoding G protein were also recognized. Recognition in this case was I-Ad-restricted, as anti-I-Ad monoclonal antibodies blocked stimulation, and an Ia-negative cell (P815) expressing a transfected G protein gene failed to stimulate the hybridomas. Even after paraformaldehyde fixation, G gene-transfected, Ia-positive cells could stimulate the hybridomas, suggesting that processing of this endogenously-synthesized antigen has occurred.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2853279     DOI: 10.1016/0882-4010(88)90033-2

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  6 in total

1.  Characterization of T-helper epitopes of the glycoprotein of vesicular stomatitis virus.

Authors:  C Burkhart; G Freer; R Castro; L Adorini; K H Wiesmüller; R M Zinkernagel; H Hengartner
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

2.  A transcript from the long terminal repeats of a murine retrovirus associated with trans activation of cellular genes.

Authors:  S Y Choi; D V Faller
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

3.  Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice.

Authors:  B S Huneycutt; Z Bi; C J Aoki; C S Reiss
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

4.  Murine infection by vesicular stomatitis virus: initial characterization of the H-2d system.

Authors:  J M Forger; R T Bronson; A S Huang; C S Reiss
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

5.  Inhibition of vesicular stomatitis virus infection by nitric oxide.

Authors:  Z Bi; C S Reiss
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

6.  Processing of a viral glycoprotein in the endoplasmic reticulum for class II presentation.

Authors:  S M Bartido; S Diment; C S Reiss
Journal:  Eur J Immunol       Date:  1995-08       Impact factor: 5.532

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.